FIG. 2.

Evolution of immunological parameters during the study period. Months 0 to 12, patients were on cART. At month 12 cART was discontinued (shady area) [■ and black line, detectable (≥200 copies/ml) group; Δ and gray line, undetectable group]. (A–D) T cell subsets (CD4⁺, CD4⁺CD38⁺HLADR⁺, CD8⁺, and CD8⁺CD38⁺). (E–F) Lymphoproliferative responses against phytohemagluttinin (PHA) 1% and HIV p24. (G–H) HIV-specific CD8⁺ T cell responses against gag peptides p1, p2, p6, and p7 (small pool) and quotient between whole CD8⁺ T cell responses (SFC/10⁶ PBMCs) and number of positive peptides detected. Median and interquartile range are shown.